Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)

US National Institutes of Health (NIH) grant open #PAR-25-243

Response due Jan 07, 2028 · 00:00 UTC

Summary

This NIH funding opportunity (PAR-25-243) solicits basic research focused on cancer health disparities under the R01 grant mechanism. Clinical trials are explicitly not allowed under this announcement. The opportunity is issued by the National Institutes of Health (HHS) and is open for submissions over a multi-year window from late 2024 through early 2028. Awards are intended to support investigator-initiated scientific research into the biological, social, and/or environmental underpinnings of cancer disparities across populations.

What they want

Funding opportunity for basic research investigating cancer health disparities. Applicants must propose non-clinical-trial research that addresses underlying mechanisms or factors contributing to disparate cancer outcomes among different population groups. Submissions are made through the standard NIH R01 grant application process. No clinical trials are permitted under this notice.

Technical requirements

No clinical trials permitted
Must follow NIH R01 grant application requirements
Research must address cancer health disparities at the basic science level

How they evaluate

Submission: NIH Grants.gov electronic submission portal (standard R01 application package)

Risks & flags

Multi-year open window (2024–2028) with rolling submission — specific due dates for each cycle not provided in the source text, limiting actionability
Absence of budget cap or award size information makes competitive positioning difficult

Market context

inferred from NAICS

Professional, Scientific & Technical Services

NAICS 541711

US market size: $2.0T
Typical award: $25K – $50M

Typical buyers

All federal civilianDoDStates

Commonly required

8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

Basic Research in Cancer Health Disparitie…

Due Jan 07

Onboard ↗